ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2020

Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial.

Nuntakorn Thongtang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.